Bonus Episode: Damien Garland - Patient Experience of MR Linac Treatment for Prostate Cancer

**Trigger Warning**Naman Julka-Anderson and Jo McNamara catch up with Damien Garland to hear his experience of Prostate Cancer and treatment on the MR Linac at The Royal Marsden NHS Foundation Trust. To use this podcast as CPD, look at these reflection points: 1) reflect on Damien’s experience of prostate cancer.2) reflect on how you can improve patient experience for people undergoing treatment in your department.3) consider ways to improve awareness of mental health issues for men.Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.Links from podcast:The Royal Marsden NHS Foundation Trust: https://www.royalmarsden.nhs.uk/Prostate Cancer UK Charity: https://prostatecanceruk.org/Mental Health UK Charityhttps://mentalhealth-uk.org/mens-mental-health/Mind Charity - a report on men’s health: https://www.mind.org.uk/about-us/our-policy-work/reports-and-guides/get-it-off-your-chest-a-report-on-men-s-mental-health/MR-Linac Consortium Website: https://mrlconsortium.orgPlease like and subscribe to Rad Chat on your podcast library.Our links:Link Tree:https://linktr.ee/radchat Facebook:https://www.facebook.com/RadChatPodcast/ Instagram:https://www.instagram.com/rad__chat/ LinkedIn:https://uk.linkedin.com/company/radtalk Tik Tok:https://www.tiktok.com/@rad_chat Twitter:https://twitter.com/rad__chat?lang=en YouTube: https://www.youtube.com/@radchat2259Music and jingle credits: Dr. Ben Potts and Adam Cooke.© Rad Chat 2025. All rights reserved.  We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  You must not use any images, audio, video, graphics or clips separately from their accompanying context.  Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.